Chantil's Shared Resources

Systemic Impacts of MASLD on Heart-related Diseases
This review provided a comprehensive analysis of the extrahepatic manifestations of metabolic dysfunction-associated steatohepatitis (MASH), focusing on chronic diseases related...

Non-invasive Tests Show Promise for Identifying High-Risk MASH
This multicenter cross-sectional study evaluated the diagnostic performance of non-invasive tests (NITs) in detecting metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis...

NAFLD: Fatty Liver Disease Linked to Obesity, Inflammation, and Liver Damage
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease globally, characterized by the accumulation of fat in more...

NAFLD: A Global Liver Disease Linked to Obesity, Managed by Lifestyle and Medication
Nonalcoholic fatty liver disease (NAFLD) is the most common liver condition globally, often associated with metabolic syndrome (MetS) and cardiovascular...

NAFLD Affects 37% of US Adults, Driving New Care Pathway for Better Screening and Treatment
Nonalcoholic fatty liver disease (NAFLD) affects about 37% of adults in the United States and up to 70% of individuals...

A Growing Liver Disease Linked to Metabolic Imbalances, Inflammation
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, affecting around 30% of...